# Globe Life Discloses $7 Million in Excess Medicare Supplement Claims as Shares Fall 8%

> Globe Life disclosed $7 million in excess Medicare Supplement claims tied to a CMS processing delay, and shares fell over 8% as an investigation opened.

- Published: 2026-10-27T00:11:06+00:00
- Section: Legal & Disputes
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-27/globe-life-medicare-claims-investigation
- Source: [PR Newswire](https://www.prnewswire.com/news-releases/globe-life-inc-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-globe-life-inc-gl-302919923.html)

## Key takeaways

- Globe Life disclosed approximately $7 million in excess prior-period Medicare Supplement claims tied to a CMS processing delay.
- United American, Globe Life's Medicare Supplement division, reported a negative $6 million health underwriting margin on $219 million in health premiums for the quarter ended September 30, 2026.
- SueWallSt, powered by Levi & Korsinsky LLP, notified investors of a pending investigation into potential securities law violations concerning Globe Life's disclosure of its CMS claims exposure.

Globe Life Inc. disclosed approximately $7 million in excess prior-period Medicare Supplement claims tied to a processing delay at the Centers for Medicare & Medicaid Services, and its shares fell over 8% on October 23, 2026. SueWallSt notified investors of a pending investigation into potential securities law violations, according to [PR Newswire](https://www.prnewswire.com/news-releases/globe-life-inc-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-globe-life-inc-gl-302919923.html).

## Globe Life's Third-Quarter Claims Disclosure

The excess claims landed in United American, the [Globe Life](https://akta.pro/company-profiles/0002zlc/globe-life) division that writes Medicare Supplement coverage. For the quarter ended September 30, 2026, United American reported a health underwriting margin of negative $6 million on $219 million in health premiums. Globe Life said the excess claims related to prior periods and were paid because of the CMS processing delay. United American's health premiums rose 29% year over year, and health sales climbed 95% to $48 million. Globe Life reported the CMS-related claims with its third-quarter results on October 22, 2026.

The investigation concerns whether Globe Life may not have adequately disclosed its exposure to CMS claims-processing changes before that date. Joseph E. Levi, Esq. of [Levi & Korsinsky](https://akta.pro/company-profiles/00026sm/levi-korsinsky) said investors who bought Globe Life stock and are looking at losses can submit their loss details. "Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares," the notice states.

## Globe Life's Scale and Capital Moves

Globe Life is a publicly traded U.S. insurance holding company that underwrites life insurance, supplemental health, Medicare Supplement, and group benefits for middle-income American households through 17,000 captive agents and direct-to-consumer channels, according to akta.pro [company records](https://akta.pro/company-data). The same records show full-year 2025 revenue of $6.02 billion and a market capitalization of $13.65 billion as of June 2026, when the stock reached an all-time high of $176.31. In April 2026, Globe Life completed a $1.2 billion Bermuda reinsurance transaction through its newly established Globe Life Re Ltd. subsidiary.

## Earlier Globe Life Developments

On October 26, 2026, Levi & Korsinsky commenced an investigation into Globe Life for potential securities fraud, after shares fell 8.09% when management cut its full-year 2026 earnings outlook, citing health-insurance underwriting pressures and a third-quarter earnings miss, [The future of trading](https://akta.pro/news-signals) reported. Globe Life set its third-quarter 2026 earnings release for October 21, 2026, with a conference call, Stock Titan reported on October 19, 2026. In September 2026, Globe Life reported second-quarter revenues of $1.59 billion, up 6.1% year on year, but missed book value and EPS estimates, sending its stock down 7% to $171.17, Yahoo reported.

## What Comes Next for Globe Life

Globe Life released its third-quarter 2026 financial results after the market close on October 21, 2026, and held a conference call for the release. The SueWallSt investigation remains pending, and investors may submit brokerage records showing purchase dates, share quantities, and prices paid.

## Companies in this story

- [Globe Life company profile](https://akta.pro/company-profiles/0002zlc/globe-life) · website: https://www.globelifeinsurance.com
- [SueWallSt.com company profile](https://akta.pro/company-profiles/00st1t3/suewallst-com) · website: https://www.suewallst.com
- [Levi & Korsinsky company profile](https://akta.pro/company-profiles/00026sm/levi-korsinsky) · website: http://www.zlk.com

---
News for Agent · https://newsforagent.com/llms.txt